Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM). Conference

Villalona-Calero, Miguel Angel, Diaz, John Paul, Diaz, Zuanel et al. (2019). Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM). . JOURNAL OF CLINICAL ONCOLOGY, 37(15), 10.1200/JCO.2019.37.15_suppl.2555

cited authors

  • Villalona-Calero, Miguel Angel; Diaz, John Paul; Diaz, Zuanel; Duan, Wenrui; Schroeder, Eric Douglas; Aparo, Santiago; Gatcliffe, Troy Antony; Alonso, Alfredo Pedro; Cuitiva, Sebastian; Albrecht, Federico; Venkatappa, Siddhartha A; Guardiola, Victor; Troner, Michael B; Garrido, Sara M; Walker, Gail; Rubens, Muni; De Zarraga, Fernando I; Hao, Vuong

authors

date/time interval

  • May 31, 2019 -

publication date

  • May 20, 2019

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • Chicago, IL

Digital Object Identifier (DOI)

Conference

  • Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

publisher

  • AMER SOC CLINICAL ONCOLOGY

volume

  • 37

issue

  • 15